Clinical trial Recruiting at 1 site Interventional Ages 13 to 18

Using auricular nerve stimulation to help adolescents with self-injury

Official title: Pilot Study on the Acceptability of Auricular Vagus Nerve Neurostimulation for the Prevention of Non-suicidal Self-injury Recurrence in Adolescents

Run by Centre Hospitalier Régional Metz-Thionville · NCT06433583 · Data updated 2026-11-12

This study is testing if a new type of nerve stimulation can help teenagers who hurt themselves feel better and find it acceptable as a treatment option.

Quick facts

Study typeInterventional
Ages13 Years to 18 Years
SexAll
Enrollment22 (estimated)
SponsorCentre Hospitalier Régional Metz-Thionville
Academic / other
Locations2 sites (Metz, Grand Est and 1 other locations)
StatusRecruiting
StartedNovember 28, 2024
Main results expectedNovember 28, 2028
Study endsNovember 28, 2028
Registry record updatedOctober 22, 2026
Trial IDNCT06433583 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adolescents aged 13 to 17 who have been diagnosed with non-suicidal self-injury disorder.

Probably not a fit

Patients with contraindications to taVNS, such as certain cardiac conditions or active implantable devices, will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot study investigates the acceptability of transcutaneous auricular vagus nerve stimulation (taVNS) in adolescents aged 13 to 17 who engage in non-suicidal self-injury (NSSI). The study aims to explore how this neurostimulation technique can influence the autonomic nervous system and potentially alleviate symptoms associated with NSSI. Given the rising prevalence of NSSI among adolescents, especially during the COVID-19 pandemic, this approach seeks to provide an alternative to traditional psychiatric interventions, which are often limited in availability and efficacy. Participants will receive taVNS treatment while their responses and experiences will be monitored to assess the intervention's acceptability.

Why it matters

Potential benefit: If successful, this approach could offer a novel, non-invasive treatment option for adolescents struggling with self-injury behaviors.

How similar studies have gone: While taVNS has been studied for various conditions, this specific application in adolescents with NSSI is relatively novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adolescents aged between 13 and 17 years old
* Patients with NSSI disorder as defined by DSM-5
* Patient affiliated to a social security scheme
* Patient who parents or guardians have signed a free and informed consent form
* Patient able to understand neurostimulation instructions

Exclusion Criteria:

* Contraindication to taVNS:
* Malformation, skin pathology of the external ear. (piercings in the area concerned must be removed during the neurostimulation session).
* Children with sleep apnea syndrome treated with NIV (non-invasive ventilation)
* Presence of epileptic seizures
* Proven cardiac pathology on the advice of the attending cardiologist
* History of venous or arterial thrombosis
* Adolescent with pacemaker or defibrillator
* Adolescent with an active implantable device
* Pregnancy (based on anamnestic criteria, checked by blood test if necessary)
* Patients with psychotic episodes, confusional states or severe neurodevelopmental disorders
* Patients with an allergic skin reaction to silicone (component of the ear electrode)
* Patients with a cochlear implant on the stimulation side
* Pregnant or breast-feeding women
* Minor under guardianship
* Minor under judicial measure or sanction

Where it's running

  • Centre Médico-Psychologique adolescents - CHR Metz-Thionville
    Thionville, France
    Recruiting
  • Etablissement Publique de Santé Mentale (EPSM) Metz-Jury
    Metz, Grand Est, France
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.